Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutation and bcl-2 expression in transitional cell carcinoma of the urinary bladder.

Zhonghua yi xue za zhi = Chinese medical journal; Free China ed - 1 Jan 2001

Wu T T, Lee Y H, Huang J K

Abstract excerpt

BACKGROUND: The purpose of our study was to examine the frequency of p53 mutation and bcl-2 expression in transitional cell carcinoma of the urinary bladder and their clinicopathologic correlates. METHODS: A total of 137 patients who underwent transurethral resection for primary transitional cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Carcinoma, Transitional Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Mutation

Share to Proto-Oncogene Proteins c-bcl-2

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 11310375

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-11310375-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutation and bcl-2 expression in transitional cell carcinoma of the urinary bladder.PMID 11310375Read ↗

The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma.Semantic proximity Read ↗

Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.Semantic proximity Read ↗

Prognostic implications of p53 gene mutations in bladder tumors.Semantic proximity Read ↗

Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.Semantic proximity Read ↗

Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.Semantic proximity Read ↗

Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.Semantic proximity Read ↗

bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.Semantic proximity Read ↗

[Gene p53 mutation and prognosis in bladder tumors].Semantic proximity Read ↗

The p53 Pathway and Outcome among Patients with T1G3 Bladder TumorsSemantic proximity Read ↗

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.Semantic proximity Read ↗

Mutation of the p53 tumor suppressor gene in transitional cell carcinoma of the urinary tract in Taiwan.Semantic proximity Read ↗

Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.